Literature DB >> 187406

Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin.

C Rivier, W Vale, N Ling, M Brown, R Guillemin.   

Abstract

Morphine sulfate (MS) and the opioid peptide beta-endorphin beta-LPH-(61-91) stimulate prolactin and growth hormone release in steroid-primed and non-treated male rats when injected intravenously or intracisternally. On a molar basis beta-endorphin is at least 20 times more potent than MS, whereas Met5-enkephalin (beta-LPH-(61-65)) and alpha-endorphin (beta-LPH-(61-76)) are devoid of activity at the dose injected (300 mug). The in vivo stimulatory effects of beta-endorphin on prolactin secretion are reversed by the opiate antagonist naloxone. The absence of in vitro effect of MS and beta-endorphin on prolactin and growth hormone secretion by cultured rat pituitary cells suggest that they have a central nervous system site of action.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 187406     DOI: 10.1210/endo-100-1-238

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  37 in total

1.  Morphometrical variations of prolactin cells in response to prolonged and systemic administration of Met-enkephalin in female rats.

Authors:  J Carretero; E Blanco; F Sánchez; J M Riesco; M Rubio; J A Juanes; R Vázquez
Journal:  Anat Embryol (Berl)       Date:  1992

Review 2.  The enkephalins. Peptides with morphine-like activity.

Authors:  R J Miller; P Cuatrecasas
Journal:  Naturwissenschaften       Date:  1978-10

Review 3.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

Review 4.  Ontogenic studies of the neural control of adenohypophyseal hormones in the rat. II. Prolactin.

Authors:  D Becú-Villalobos; I M Lacau-Mengido; G S Díaz-Torga; C Libertun
Journal:  Cell Mol Neurobiol       Date:  1992-02       Impact factor: 5.046

5.  Effects of naloxone infusion on nocturnal prolactin secretion and Fos/FRA expression in pregnant rats.

Authors:  Y Hou; J L Voogt
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

6.  Methysergide decreases prolactin release after FK 33-824 [Tyr-D-Ala-Gly-MePhe-Met(o)-ol], a potent analogue of methionine enkephalin. A study in man.

Authors:  G Jungkunz; N Nedopil; E Rüther
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  Prolactin and growth hormone releasing activity of [D-Met2, Pro5]-enkephalinamide in the rat after systemic administration.

Authors:  V Locatelli; D Cocchi; S Bajusz; S Spampinato; E E Müller
Journal:  Experientia       Date:  1978-12-15

8.  Opiate antagonistic properties of an octapeptide somatostatin analog.

Authors:  R Maurer; B H Gaehwiler; H H Buescher; R C Hill; D Roemer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

9.  A possible role of endogenous opioids in the control of prolactin and luteinizing-hormone secretion in the human.

Authors:  J D Veldhuis; T J Worgul; R Monsaert; J M Hammond
Journal:  J Endocrinol Invest       Date:  1981 Jan-Mar       Impact factor: 4.256

10.  beta-Endorphin: analgesic and hormonal effects in humans.

Authors:  K M Foley; I A Kourides; C E Inturrisi; R F Kaiko; C G Zaroulis; J B Posner; R W Houde; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.